Yomi S Robotic System
Neocis, Inc. · Decision date Oct 13, 2026
What did the FDA decide?
The FDA's 510(k) final decision list records K261321 for the Yomi S Robotic System, submitted by Neocis, Inc., with a decision of substantially equivalent (SESE) and a published date of 13 October 2026. The record places the device in the dental specialty under product code QRY. Substantial equivalence is a 510(k) clearance, not a premarket approval of the device.
The source identifies the applicant and device name but does not describe the specific components, design changes or indications covered by this submission, nor does it state a predicate device or the basis for the equivalence finding. Those details would sit in the underlying 510(k) review documents rather than the decision listing. The same listing also carries unrelated clearances, including K261572 and K252288, which are separate submissions and not part of this record.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Dental
- Decision date
- Oct 13, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261321
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Neocis, Inc.
- Product code
- QRY
- Decision code
- SESE
- Decision date
- Oct 13, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Dental Navigation System.
- Applicant
- Neocis, Inc.
- Product code
- QRY
- FDA device class
- 2
FDA decision timeline
K261321 received
Application receipt date recorded by FDA.
K261321 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Neocis, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Miami, FL
Sources and methodology
- Original FDA record: K261321
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records